Executive Director, Neurodegeneration Strategy & Commercial

Bristol-Myers Squibb Co; Princeton (NJ); On-site; USD 239,000 - 290,000; Full time

Job summary

Bristol Myers Squibb seeks an Executive Director, Strategy & Commercial Development, Neuroscience to lead the commercial strategy for a rapidly expanding neurodegeneration portfolio, spanning Alzheimer's, Parkinson's/DLB, and other conditions. Own market development, biomarker strategy, and cross-functional alignment with development, medical, and regulatory teams.

The role partners with markets worldwide, BI&A, and VAP to ensure favorable launch conditions, and drives long-range plans through

Qualifications

• BA/BS required; life sciences degree or equivalent desirable. MBA / graduate degree highly preferred.
• At least 12 years of progressive industry experience with a proven track record of success across products in various stages of development, from pipeline to launch to in-market
• US and Global experience preferred
• Functional experience within Alzheimer's Disease and/or movement disorders (Parkinson's/DLB) preferred
• Demonstrated scientific acumen; understanding of drug development processes and regulatory pathways, product design, and new product evaluation
• Understanding of the commercial aspects of drug development, including global/country market dynamics, operational feasibility, market access, patient advocacy, and regulatory and reimbursement challenges across domestic and international markets
• Demonstrated people-leadership experience, including managing and developing direct reports
• Collaborates across the organization to incorporate the needs of internal and external stakeholders in the commercial planning process
• Ability to critically assess opportunities with disciplined thinking to determine what is best for patients and the business, and to influence and build alignment with stakeholders
• Strong financial acumen, with the ability to assimilate complex information to create and manage budgets and meet financial targets
• Proven track record demonstrating breadth and depth of experience across marketing competencies and exemplary achievement of performance objectives
• Demonstrated experience leading strategically, communicating with impact, and creating a strong, inclusive, energizing culture consistent with BMS values
• Experience mobilizing matrix team members and embracing teamwork within a cross-functional environment
• Knowledge of AI resources and how to utilize to enhance productivity and quality outputs.

Responsibilities

• Leads worldwide brand planning and long-range forecasting across the neurodegeneration pipeline, including assets from Discovery through Phase 2b/3 in Alzheimer’s, Parkinson’s, and other neurodegenerative conditions.
• Owns Neurodegeneration Market Development, including biomarker and diagnosis strategy, patient identification pathways, and preparation of markets for launch
• Sets the strategic direction for neurodegeneration and also ensuring alignment of day-to-day execution with overall franchise strategy
• Ensures comprehensive assessment of competitive data and events, assesses emerging trends that could impact brands, and integrates implications into brand strategy and plans in rapidly evolving spaces that are new to BMS
• Translates new clinical and scientific evidence into brand strategy to maximize opportunities for appropriate patient usage
• Partners with opinion leaders, advocacy groups, external agencies, and other stakeholders to reinforce BMS's commitment to neurodegeneration, and to build BMS's presence in these areas
• Partners with WW Value, Access, and Pricing team to ensure optimized access and uptake at launch through optimized development strategies that meet future market needs
• Builds a deep understanding of local market dynamics, including customer and competitive insights, and identifies growth opportunities to drive global development and launch
• Leads and influences across functions and levels to guide optimized development for future commercial success
• Develops the strategic and long-range plan for neurodegeneration and guides products through successful transition at key stage gates, representing key products to Executive Management
• Demonstrates the ability to develop strategies and build relationships with stakeholders to establish BMS's presence in new neurodegeneration therapeutic areas

Skills

Leadership

Strategic planning

Cross-functional collaboration

Commercial acumen

Drug development knowledge

Financial acumen

Team management

Education

BA/BS

MBA

Job description

Bristol Myers Squibb seeks an Executive Director, Strategy & Commercial Development, Neuroscience to lead the commercial strategy for a rapidly expanding neurodegeneration portfolio, spanning Alzheimer's, Parkinson's/DLB, and other conditions. Own market development, biomarker strategy, and cross-functional alignment with development, medical, and regulatory teams.

The role partners with markets worldwide, BI&A, and VAP to ensure favorable launch conditions, and drives long-range plans through